For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Verseon Corporation

USPTO Granted Patents = 15

% Expired Patents = 26.7

CIPO Patents = 2

EPO Patents = 6

Forward Citations = 58

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

David B Kita (11 out of 26 patents)

Kevin Michael Short (10 out of 11 patents)

Son Minh Pham (9 out of 9 patents)

4. David Charles Williams (8 out of 9 patents)

5. Somalee Datta (5 out of 6 patents)

6. Adityo Prakash (5 out of 40 patents)

7. Eniko Fodor (5 out of 22 patents)

8. Maria De Los Angeles Estiarte-Martinez (2 out of 3 patents)

9. Timothy Philip Shiau (1 out of 1 patent)

10. Sachin Ahuja (1 out of 5 patents)

11. David Ben Kita (0 patent)

12. Kita David (0 patent)

13. Fodor Eniko (0 patent)

14. Prakash Adityo (0 patent)

15 patents: Sort by Forward Citations

1. 10653674 - Multisubstituted aromatic compounds as inhibitors of thrombin (2020-05-19),

2. 10532995 - Substituted pyrazole compounds as serine protease inhibitors (2020-01-14),

3. 10251872 - Multisubstituted aromatic compounds as serine protease inhibitors (2019-04-09),

4. 10189810 - Pyrazolyl-substituted pyridone compounds as serine protease inhibitors (2019-01-29),

5. 10058541 - Multisubstituted aromatic compounds as serine protease inhibitors (2018-08-28),

6. 9963440 - Multisubstituted aromatic compounds as inhibitors of thrombin (2018-05-08),

7. 9951025 - Halogenopyrazoles as inhibitors of thrombin (2018-04-24),

8. 9687479 - Multisubstituted aromatic compounds as serine protease inhibitors (2017-06-27),

9. 9533970 - Multisubstituted aromatic compounds as serine protease inhibitors (2017-01-03),

10. 9533967 - Multisubstituted aromatic compounds as inhibitors of thrombin (2017-01-03),

11. 9317664 - Method and device for partitioning a molecule (2016-04-19),

12. 8036867 - Method and apparatus for analysis of molecular configurations and combinations (2011-10-11),

13. 7890313 - Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions (2011-02-15),

14. 7751988 - Lead molecule cross-reaction prediction and optimization system (2010-07-06),

15. 6970790 - Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions (2005-11-29),

Verseon Corporation is a pharmaceutical company that utilizes its proprietary platform to discover and develop innovative drug candidates. The company focuses on applying computational technology to expedite the drug discovery process and enhance success rates in clinical trials. Verseon's rigorous approach to drug design enables the identification of effective, safe, and targeted therapies for various diseases. Through strategic partnerships and collaborations, Verseon aims to bring transformative medicines to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

15 Patents

#129 in Fremont, CA

#5,018 in California

#21,011 in US

#39,801 in the World

Fremont, CA, United States of America

Verseon Corporation

Forward Citations = 58

10 inventors:

David B Kita (11 out of 26 patents)

Kevin Michael Short (10 out of 11 patents)

Son Minh Pham (9 out of 9 patents)

4. David Charles Williams (8 out of 9 patents)

5. Somalee Datta (5 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…